This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi Chimie. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Michael Kleser: Innovator in Biocatalysis
Introduction
Michael Kleser is a notable inventor based in Völklingen, Germany. He has made significant contributions to the field of biocatalysis, particularly through his innovative work with cytochrome P450 monooxygenases. His research focuses on the development of whole-cell systems that can convert substrates into valuable biotechnological products.
Latest Patents
Kleser holds a patent for a whole-cell catalysis process that utilizes cytochrome P450 monooxygenases of eukaryotic origin. This invention enables the conversion of specific substrates into high-value products through genetically engineered microorganisms. The patent highlights the processes involved in preparing these microorganism strains to achieve efficient biotransformations.
Career Highlights
Throughout his career, Michael Kleser has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Sanofi Chimie and Sanofi, where he has contributed to various projects that leverage biocatalysis for industrial applications.
Collaborations
Kleser has collaborated with several professionals in his field, including Adrian Gerber and Frank Hannemann. These collaborations have furthered his research and development efforts in biocatalysis.
Conclusion
Michael Kleser is a distinguished inventor whose work in biocatalysis has the potential to impact various industries. His innovative approaches and patented technologies continue to pave the way for advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile